Categories: News

Cognidox rolls out new training analytics and project cloning features in v10.2

Cambridge, UK, 4 May 2022: Cognidox, a leading provider of document management solutions for the high-tech, medical device, and life sciences industries, has unveiled the latest innovations in its v10.2 platform release.

The Q2 rollout of Cognidox 10.2 includes a new training analytics dashboard, project master cloning capabilities, improvements to shared notes, a new search engine, new login screens and more flexible two-factor authentication (2FA) options.

Joe Byrne, CEO of Cognidox, describes the two major enhancements driving the release:

Training analytics
“Cognidox’s new training analytics dashboard gives companies a comprehensive overview of workers’ acknowledgement of critical policies and procedures. Users can now track training attestation in a simple matrix view, helping meet some of the critical reporting requirements of ISO 13485:2016 and other quality standards.”

Project cloning
With Cognidox v10.2 setting up new projects and multiple LAP partner areas has never been easier:

“Developers and consultants can now clone existing project structures at the touch of a button. Every document within an existing structure can be replicated instantly and renamed to support a brand new client or NPI process.”

There are also upgrades for shared notes capabilities, including a new rendering engine, mouse controls and editing features. Meanwhile, the release enables 2 Factor Authentication with a new MySQL Password plugin.

Cognidox continues to improve clients’ document control capabilities with its new and powerful features, making the platform ever faster and more intuitive.

About Cognidox
Cognidox is a leading document management software provider for the high-tech, medical device, and life science product sectors. The Cognidox DMS improves visibility and control for the development process and an entire business.

Founded in 2008 by Vittal Aithal and Paul Walsh, the Cambridge based company started life as “Doxbox” – an in-house tool for the fabless semiconductor company Virata. The goal was to make product development better by breaking down barriers between teams and making peer reviews much easier.

Today, it is powering the development of cutting-edge products in the semiconductor, medical device and IVD device industries. Its lean DMS supports customers in creating more efficient, sustainable and compliant product development processes. It helps companies build robust Quality Management Systems that can flex with their needs.

Cognidox is validated for use with ISO 13485, ISO 9001, FDA 21 CFR 820, FDA 21 CFR 11, ISO 26262 and GxP.

To find out more about Cognidox, visit the website: https://www.cognidox.com/

For more information:
Joe Byrne
Cognidox
+44 (0)1223 911080
joe.byrne@cognidox.com

Source: RealWire

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

4 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

6 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

6 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

6 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

6 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

6 hours ago